Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial

BACKGROUND: Diabetic foot osteomyelitis (DFO) poses a major disease burden. It can generally be treated with long-term antibacterial therapy. International guidelines recommend to base antibacterial therapy choices on percutaneous bone biopsy culture, while in practice, therapy is frequently based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramberg, Meryl Cinzía Tila Tamara, Lagrand, Rimke Sabine, Sabelis, Louise Willy Elizabeth, den Heijer, Martin, de Groot, Vincent, Nieuwdorp, Max, Kortmann, Willemijn, Sieswerda, Elske, Peters, Edgar Josephus Gerardus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335883/
https://www.ncbi.nlm.nih.gov/pubmed/34344428
http://dx.doi.org/10.1186/s13063-021-05472-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335883/
https://www.ncbi.nlm.nih.gov/pubmed/34344428
http://dx.doi.org/10.1186/s13063-021-05472-6

Ejemplares similares